Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

1,240 studies match

clinicaltrialsPublishedShowing 151–200 of 1,240 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06989112	DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer(DE-01)	recruiting	Phase 3	600	AstraZenecaINDUSTRY	23	Sep 3, 2026	clinicaltrials
NCT06652438	Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML	recruiting	Phase 3	448	Stichting Hemato-Oncologie voor Volwassenen NederlandOTHER